CNR1 and metabolic dysfunction-associated steatotic liver disease: Although CBD has a therapeutic effect on MASLD, alcoholic liver disease, viral hepatitis, and liver fibrosis, further research is needed to determine whether CBD’s antagonistic effect on CB1 can improve its adverse impact on the liver.